Intravenous thrombolysis for ischemic stroke in recurrent oligodendroglioma: a case report.
Data on efficacy and safety of intravenous (IV) thrombolysis with recombinant tissue plasminogen activator (rtPA) in patients with acute ischemic stroke (AIS) and intracranial neoplasm are lacking. To date, only a handful of case reports have been published in the literature addressing the administration of IV rtPA to patients with AIS and coexisting brain neoplasms. We present the case of successful IV thrombolysis with rtPA for AIS in a patient with oligodendroglioma on bevacizumab without hemorrhagic complications. We summarize the published cases of thrombolysis in AIS in patients with intracranial neoplasms.
['Dafer|Rima M|RM|', 'Paleologos|Nina|N|', 'Lynch|Deborah|D|']
D020533:Angiogenesis Inhibitors D061067:Antibodies, Monoclonal, Humanized D000068258:Bevacizumab D002545:Brain Ischemia D001932:Brain Neoplasms D038524:Diffusion Magnetic Resonance Imaging D005260:Female D005343:Fibrinolytic Agents D006801:Humans D007262:Infusions, Intravenous D008875:Middle Aged D009364:Neoplasm Recurrence, Local D009837:Oligodendroglioma D011994:Recombinant Proteins D020521:Stroke D015912:Thrombolytic Therapy D010959:Tissue Plasminogen Activator D016896:Treatment Outcome
Thrombolysis ischemic stroke oligodendroglioma brain tumors